|
|
Other links at Articles > Pharmacists |
| 1. |
Infliximab for Rheumatoid Arthritis Seen Safe in Japanese Patients
|
|
|
Results of a post-marketing surveillance study in Japan provide a "real world" picture of the incidence of adverse reactions associated with infliximab therapy for rheumatoid arthritis (RA), according to a Japanese research team. They conclude that the safety profile is acceptable. Reuters Health Information
|
|
|